Rapid formation of Aspergillus mycetoma in a patient receiving corticosteroid treatment. Serial radiographic observation over two months

Internal Medicine

Volumn 46, Issue 11, 2007, Pages 733-738

  Akimoto, Tetsu ^a   Saito, Osamu ^a   Inoue, Makoto ^a   Nishino, Katsuhiko ^a   Onishi, Akira ^a   Kotoda, Atsushi ^a   Ando, Yasuhiro ^a   Muto, Shigeaki ^a   Kusano, Eiji ^a  

^a Division of Nephrology   (Japan)

Author keywords

Aspergilloma; Chronic necrotizing pulmonary aspergillosis; Immunosuppression; MPO ANCA; Renal failure

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; COTRIMOXAZOLE; FLUCONAZOLE; METHYLPREDNISOLONE; MICAFUNGIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; TUBERCULOSTATIC AGENT;

ACUTE RESPIRATORY FAILURE; ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; ASPERGILLUS; CASE REPORT; CLINICAL FEATURE; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE ASSOCIATION; DISEASE COURSE; DYSPNEA; FEMALE; FUNGUS HYPHAE; HEMODIALYSIS; HEMOPTYSIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; KIDNEY FAILURE; LUNG ASPERGILLOSIS; LUNG INFILTRATE; LUNG INJURY; LUNG RESECTION; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; REMISSION; THORAX RADIOGRAPHY;

ADRENAL CORTEX HORMONES; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, FUNGAL; MADUROMYCOSIS; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; VASCULITIS;

EID: 34250211478     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6238     Document Type: Article

References (22)

1. Agusti C, Rano A, Filella X, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment. Chest 123: 488-498, 2003.
2. Akimoto T, Ando Y, Ito C, Muto S, Kusano E, Asano Y. Effect of plasmapheresis as initial monotherapy in a case of anti-neutrophil cytoplasmic autoantibody positive crescentic glomerulonephritis. ASAIO J 45: 509-513, 1999.
3. Donnelly JP. Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients? J Intern Med 242(suppl 740): 79-88, 1997.
4. Fukushima C, Shimoda T, Kawano T, et al. Effects of amphotericin B gargles on oral colonization of candida albicans in asthmatic patients on steroid inhalation therapy. Respiration 68: 465-470, 2001.
5. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 121: 1988-1999, 2002.
6. Tomlinson JR, Sahn SA. Aspergilloma in sarcoid and tuberculosis. Chest 92: 505-508, 1987.
7. British Thoracic and Tuberculosis Association. Aspergilloma and residual tuberculosis cavities. The results of a re-survey. Tubercle 51: 227-245, 1970.
8. Izumi A, Mori T. A clinical analysis of 66 pulmonary aspergillosis. Jpn J Med Mycol 30: 173-181, 1989.
9. Kurashima A. Analysis of the course of non-invasive pulmonary aspergillosis. Jpn J Med Mycol 38: 167-174, 1997.
10. Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: A discrete clinical entity. Medicine 61: 109-124, 1982.
11. Parra I, Remacha A, Rezusta A, Suarez D, Suarez J, Herrera JA, Gonzalez JR. Chronic necrotizing pulmonary aspergillosis. Med Mycol 42: 369-371, 2004.
12. Saraceno J, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB. Chronic necrotizing pulmonary aspergillosis. Aproach to management. Chest 112: 541-548, 1997.
13. Yousem SA. The histological spectrum of chronic necrotizing forms of pulmonary aspergillosis. Hum Pathol 28: 650-656, 1997.
14. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangitis. Clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42: 421-430, 1999.
15. Katz P. Glucocorticosteroids in relation to inflammatory disease. In: Cecil Textbook of Medicine. 21st ed. Goldman L, Bennett JC Eds. WB Saunders, Philadelphia, 2000: 111-114.
16. Glück T, Kiefmann B, Grohmann M, Falk W, Straub RH, Schölmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J Rheumatol 32: 1473-1480, 2005.
17. Furuta T, Hotta O, Horigome I, et al. Decreased CD4 lymphocyte count as a marker predicting high mortality rate in managing ANCA related rapidly progressive glomerulonephritis. Nephron 91: 601-605, 2002.
18. Schaffiner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against conidia by polymorphonuclear phagocytes in resistance to aspergillus. J Clin Invest 69: 105-111, 1982.
19. Lazzarin A, Uberti FC, Galli M, et al. Impairment of polynuclear function in patients with the acquired immune deficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol 65: 105-11, 1986.
20. Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 46: 15-20, 1991.
21. Hohler T, Schnutgen M, Wayet WJ, Meyer zum Buschenfelde KH. Pulmonary aspergilloma in a patient with AIDS. Thorax 50: 312-313, 1995.
22. Addrizzo-Harris DJ, Harkin TJ, McGuinness G, Naidich DP, Rom WN. Pulmonary aspergilloma and AIDS. A comparison of HIV-infected and HIV-negative individuals. Chest 111: 612-618, 1997.